Trial
NCT04889040
Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Hoffmann-La Roche
Collaborators
Atea Pharmaceuticals, Inc.
Condition
COVID-19
Intervention
RO7496998
Why stopped
Based on program revaluation and in agreement with the co-development partner the sponsor took the decision to terminate this study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-01-05